Antiplatelet therapy and outcome in COVID-19: the Health Outcome Predictive Evaluation Registry

Santoro, Francesco; Nuñez-Gil, Ivan Javier; Vitale, Enrica; Viana-Llamas, Maria C; Reche-Martinez, Begoña; Romero-Pareja, Rodolfo; Feltez Guzman, Gisela; Fernandez Rozas, Inmaculada; Uribarri, Aitor; Becerra-Muñoz, Víctor Manuel; Alfonso-Rodriguez, Emilio; Garcia-Aguado, Marcos; Huang, Jia; Ortega-Armas, María Elizabeth; Garcia Prieto, Juan F; Corral Rubio, Eva Maria; Ugo, Fabrizio; Bianco, Matteo; Mulet, Alba; Raposeiras-Roubin, Sergio; Jativa Mendez, Jorge Luis; Espejo Paeres, Carolina; Albarrán, Adrián Rodríguez; Marín, Francisco; Guerra, Federico; Akin, Ibrahim; Cortese, Bernardo; Ramakrishna, Harish; Macaya, Carlos; Fernandez-Ortiz, Antonio; Brunetti, Natale Daniele

Document types check

Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/87725

Title:	Antiplatelet therapy and outcome in COVID-19: the Health Outcome Predictive Evaluation Registry
Authors:	Santoro, Francesco Nuñez-Gil, Ivan Javier Vitale, Enrica Viana-Llamas, Maria C Reche-Martinez, Begoña Romero-Pareja, Rodolfo Feltez Guzman, Gisela Fernandez Rozas, Inmaculada Uribarri, Aitor Becerra-Muñoz, Víctor Manuel Alfonso-Rodriguez, Emilio Garcia-Aguado, Marcos Huang, Jia Ortega-Armas, María Elizabeth Garcia Prieto, Juan F Corral Rubio, Eva Maria Ugo, Fabrizio Bianco, Matteo Mulet, Alba Raposeiras-Roubin, Sergio Jativa Mendez, Jorge Luis Espejo Paeres, Carolina Albarrán, Adrián Rodríguez Marín, Francisco Guerra, Federico Akin, Ibrahim Cortese, Bernardo Ramakrishna, Harish Macaya, Carlos Fernandez-Ortiz, Antonio Brunetti, Natale Daniele View more
Filiation:	Hospital Universitario Príncipe de Asturias
Keywords:	COVID-19 clinical pharmacology View more
Mesh:	Aged COVID-19 Female Hospital Mortality Hospitalization Humans Male Middle Aged Platelet Aggregation Inhibitors Registries Respiration, Artificial COVID-19 Drug Treatment View more
Issue Date:	Jan-2022
Publisher:	BMJ
Citation:	Heart.2022 Jan;(108)2:130-136
Abstract:	Standard therapy for COVID-19 is continuously evolving. Autopsy studies showed high prevalence of platelet-fibrin-rich microthrombi in several organs. The aim of the study was therefore to evaluate the safety and efficacy of antiplatelet therapy (APT) in hospitalised patients with COVID-19 and its impact on survival.
PMID:	34611045
URI:	https://hdl.handle.net/20.500.12530/87725
Rights:	info:eu-repo/semantics/openAccess
ISSN:	1355-6037
Appears in Collections:	Hospitales > H. U. Príncipe de Asturias > Artículos

Files in This Item:

File	Description	Size	Format
34611045.pdf	Antiplatelet therapy and outcome in COVID-19	701.49 kB	Adobe PDF	View/Open

Show full item record

This item is licensed under a Creative Commons License